Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N-terminus of HIV-1 Tat indicate at least two inhibitor binding sites.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Biochemistry

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/J.1432-1033.2003.03568.XPMID 12752434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide

  2004cited by this paper
• Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

  2003cited by this paper
• First bite

  2003cited by this paper
• Detection of the Activity of the Ectopeptidases DPIV and APN Using Sensitive Fluorogenic Substrates

  2002cited by this paper
• Down-regulation of T Cell Activation following Inhibition of Dipeptidyl Peptidase IV/CD26 by the N-terminal Part of the Thromboxane A2 Receptor*

  2000cited by this paper
• Development of a tertiary-structure model of the C-terminal domain of DPP IV.

  2000cited by this paper
• Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.

  2000cited by this paper
• The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.

  1999cited by this paper
• Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

  1999cited by this paper
• Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).

  1999cited by this paper
• Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.

  1998cited by this paper
• Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1α

  1998cited by this paper
• Prolyl Oligopeptidase: An Unusual β-Propeller Domain Regulates Proteolysis

  1998cited by this paper
• Anti-arthritic effects of the novel dipeptidyl peptidase IV inhibitors TMC-2A and TSL-225.

  1998cited by this paper
• Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis.

  1998cited by this paper
• Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4+ T cell clones.

  1998cited by this paper
• Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage

  1997cited by this paper
• The N-terminal Structure of HIV-1 Tat Is Required for Suppression of CD26-dependent T Cell Growth*

  1997cited by this paper
• The N‐terminal X‐X‐Pro sequence of the HIV‐1 Tat protein is important for the inhibition of dipeptidyl peptidase IV (DP IV/CD26) and the suppression of mitogen‐induced proliferation of human T cells

  1996cited by this paper
• Inhibition of dipeptidyl peptidase IV (DP IV) by anti-DP IV antibodies and non-substrate X-X-Pro- oligopeptides ascertained by capillary electrophoresis.

  1995cited by this paper
• Functional role of CD26 on human B lymphocytes.

  1995cited by this paper
• Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells.

  1994cited by this paper
• Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

  1994cited by this paper
• Dipeptidyl-peptidase IV from rat liver.

  1994cited by this paper
• Regional expression of epithelial dipeptidyl peptidase IV in the human intestines.

  1994cited by this paper
• Dipeptidyl peptidase IV (DPP-IV) from pig kidney cleaves analogs of bovine growth hormone-releasing factor (bGRF) modified at position 2 with Ser, Thr or Val. Extended DPP-IV substrate specificity?

  1993cited by this paper
• Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.

  1993cited by this paper
• Direct association of adenosine deaminase with a T cell activation antigen, CD26.

  1993cited by this paper
• Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs.

  1992cited by this paper
• 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.

  1991cited by this paper
• Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

  1990cited by this paper
• Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes.

  1990cited by this paper
• Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.

  1990cited by this paper
• Validation of the general purpose tripos 5.2 force field

  1989cited by this paper
• Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

  1989cited by this paper
• 1F7, a novel cell surface molecule, involved in helper function of CD4 cells.

  1989cited by this paper
• Dipeptidyl Peptidase IV in Human T Lymphocytes

  1989cited by this paper
• Mechanism of proline-specific proteinases: (I) Substrate specificity of dipeptidyl peptidase IV from pig kidney and proline-specific endopeptidase from Flavobacterium meningosepticum.

  1988cited by this paper
• Kinetic characterization of the inhibition of purified cynomolgus monkey lactate dehydrogenase isozymes by gossypol.

  1986cited by this paper
• Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

  1985cited by this paper
• Inhibitory action of proline-containing peptides on Xaa-Pro-dipeptidylaminopeptidase.

  1982cited by this paper
• ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES

  1980cited by this paper
• Kinetic mechanism and specificity of the phosphorylase kinase reaction.

  1978cited by this paper
• Enzyme kinetics: Behavior and analysis of rapid equilibrium and steady‐state enzyme systems. Author: Irwin H. Segal (University of California, Davis). Published by Wiley‐Interscience, New York, 1975. Price: $24.50. No. of pages: 957

  1976cited by this paper
• A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide.

  1966cited by this paper

• Gastrointestinal stability of Dipeptidyl peptidase IV (DPP-IV)-inhibitory peptides identified in Tenebrio molitor

  2025cites this paper
• Protein Hydrolysis as a Way to Valorise Squid-Processing Byproducts: Obtaining and Identification of ACE, DPP-IV and PEP Inhibitory Peptides

  2024cites this paper
• Binding kinetics of highly mutated HIV-1 subtype C protease inhibition by Lopinavir and Darunavir in the face of altered conformational dynamics.

  2024cites this paper
• Food-derived Trp-rich oligopeptides: Production, bioactivities, and structure-function relationship

  2023cites this paper
• Mining and Validation of Novel Hemp Seed-Derived DPP-IV-Inhibiting Peptides Using a Combination of Multi-omics and Molecular Docking.

  2023cites this paper
• 3D-QSAR, in vitro assay and MD simulations studies on the design, bioactivities and different inhibitory modes of the novel DPP-IV inhibitory peptides

  2023cites this paper
• In silico identification of antidiabetic and hypotensive potential bioactive peptides from the sheep milk proteins-a molecular docking study.

  2022cites this paper
• Exploring the potential of Lacticaseibacillus paracasei M11 on antidiabetic, anti-inflammatory, and ACE inhibitory effects of fermented dromedary camel milk (Camelus dromedaries) and the release of antidiabetic and anti-hypertensive peptides.

  2022cites this paper
• SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack

  2021cites this paper
• HIV_A_300055 361..375

  2021cites this paper
• Silver Binding to Bacterial Glutaredoxins Observed by NMR

  2021cites this paper
• Research Progress on Dipeptidyl Peptidase Family: Structure, Function and Xenobiotic Metabolism.

  2021cites this paper
• Antidiabetic Potential of Protein Hydrolysates and Peptide Fractions from Lima Bean (Phaseolus lunatus L): An In Vitro Study

  2021cites this paper
• Structure–function engineering of novel fish gelatin-derived multifunctional peptides using high-resolution peptidomics and bioinformatics

  2021cites this paper
• iDPPIV-SCM: A sequence-based predictor for identifying and analyzing dipeptidyl peptidase IV (DPP-IV) inhibitory peptides using a scoring card method.

  2020cites this paper
• Comparative Pharmacokinetics and Pharmacodynamics of a Novel Sodium-Glucose Cotransporter 2 Inhibitor, DWP16001, with Dapagliflozin and Ipragliflozin

  2020cites this paper
• Enzymatic protein hydrolysates and ultrafiltered peptide fractions from Cowpea Vigna unguiculata L bean with in vitro antidiabetic potential

  2019cites this paper
• Evaluating in vitro dipeptidyl peptidase IV inhibition by peptides from common carp (Cyprinus carpio) roe in cell culture models

  2019cites this paper
• Features of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from dietary proteins.

  2019cites this paper
• In Silico Approaches Applied to the Study of Peptide Analogs of Ile-Pro-Ile in Relation to Their Dipeptidyl Peptidase IV Inhibitory Properties

  2018cites this paper
• Optimization of Substrate‐Analogue Furin Inhibitors

  2017cites this paper
• Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties.

  2017cites this paper
• Protein digestion and energy homeostasis: How generated peptides may impact intestinal hormones?

  2016cites this paper
• Milk Protein Hydrolysates and Bioactive Peptides

  2016cites this paper
• Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in silico and in vitro analyses

  2016cites this paper
• Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment

  2016cites this paper
• Dipeptidyl Peptidase IV-Inhibitory Peptides Derived from Silver Carp (Hypophthalmichthys molitrix Val.) Proteins.

  2016cites this paper
• Evaluation of some plants for potential dipeptidyl peptidase IV inhibitory effects in vitro

  2015cites this paper
• Kinetics of Enzyme-Modifier Interactions

  2015cites this paper
• Utilisation of the isobole methodology to study dietary peptide-drug and peptide-peptide interactive effects on dipeptidyl peptidase IV (DPP-IV) inhibition.

  2015cites this paper
• The Basic Mechanisms of Inhibition and Nonessential Activation

  2015cites this paper
• Milk proteins as a source of tryptophan-containing bioactive peptides.

  2015cites this paper
• Isolation and Identification of Dipeptidyl Peptidase IV-Inhibitory Peptides from Trypsin/Chymotrypsin-Treated Goat Milk Casein Hydrolysates by 2D-TLC and LC-MS/MS.

  2015cites this paper
• Discovery and characterization of novel bioactive peptides from marine secondary products

  2014cites this paper
• In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.

  2014cites this paper
• Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity from pepsin-treated bovine whey proteins.

  2014cites this paper
• DPP-IV, An Important Target for Antidiabetic Functional Food Design

  2014cites this paper
• Enhanced Free Radical Scavenging and Inhibition of DPP-4 and ACE Activities by Compounds from Salmon Tissues Digested in Vitro with Gastrointestinal Proteases

  2014cites this paper
• Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes.

  2014cites this paper
• Foodinformatics: Applications of Chemical Information to Food Chemistry

  2014cites this paper
• PNS1300360 34..46

  2014cites this paper
• Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates.

  2013cites this paper
• Inhibition of dipeptidyl peptidase IV and xanthine oxidase by amino acids and dipeptides.

  2013cites this paper
• Inhibition of dipeptidyl peptidase IV (DPP-IV) by tryptophan containing dipeptides.

  2013cites this paper
• Inhibition of dipeptidyl peptidase IV (DPP-IV) by proline containing casein-derived peptides

  2013cites this paper
• Characterization of Tat Antibody Responses in Chinese Individuals Infected with HIV-1

  2013cites this paper
• Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes

  2013cites this paper
• Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates

  2012cites this paper
• A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies.

  2012cites this paper
• Molecular mechanism and structural basis of interactions of dipeptidyl peptidase IV with adenosine deaminase and human immunodeficiency virus type-1 transcription transactivator.

  2012cites this paper
• Evaluation of the potential of dietary proteins as precursors of dipeptidyl peptidase (DPP)-IV inhibitors by an in silico approach

  2012cites this paper
• Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallography.

  2011cites this paper
• Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors.

  2011cites this paper
• Charakterisierung und Validierung von Inhibitoren und Liganden der Dipeptidyl-Aminopeptidase IV (DP IV)

  2010cites this paper
• UV and X‐ray structural studies of a 101‐residue long Tat protein from a HIV‐1 primary isolate and of its mutated, detoxified, vaccine candidate

  2010cites this paper
• Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors.

  2010cites this paper
• Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function.

  2008cites this paper
• Enzymatic cleavage of chemokines CCL2 and CXCL10 : Implications for multiple sclerosis pathogenesis.

  2008cites this paper
• Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.

  2008cites this paper
• Serum stability of peptides.

  2008cites this paper
• Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.

  2006cites this paper
• Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile).

  2005cites this paper
• Crystal Structures of HIV-1 Tat-derived Nonapeptides Tat-(1–9) and Trp2-Tat-(1–9) Bound to the Active Site of Dipeptidyl-peptidase IV (CD26)*

  2005cites this paper
• The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases.

  2005cites this paper
• Pops: a Computational Tool for Modeling and Predicting Protease Specificity

  2004cites this paper
• Different inhibition mechanisms of dipeptidyl peptidase IV by tryptophan containing peptides and amides.

  2003cites this paper